US Stock MarketDetailed Quotes

Genmab (GMAB)

Watchlist
  • 28.250
  • -0.030-0.11%
Close Apr 10 16:00 ET
  • 27.800
  • -0.450-1.59%
Post 17:47 ET
18.15BMarket Cap18.38P/E (TTM)

Genmab (GMAB) Revenue Breakdown Overview

By Business/Source

Currency:USD
2025/FY
Stock NameRevenueRatio
DARZALEX2.44B65.67%
Kesimpta443M11.91%
Net product sales398M10.70%
Other111M2.98%
TEPEZZA105M2.82%
Milestone revenue97M2.61%
Collaboration revenue70M1.88%
Reimbursement revenue53M1.42%
View all

By Country/Region

Currency:USD
2025/FY
Stock NameRevenueRatio
Denmark3.33B89.41%
Japan213M5.73%
United States180M4.84%
Netherlands1M0.03%
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Following the collapse of peace talks between the US and Iran, the US Central Command announced a full blockade of all vessels entering and Show More